<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37579159</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>120</Volume><Issue>34</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>22</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>WASF3 disrupts mitochondrial respiration and may mediate exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome.</ArticleTitle><Pagination><StartPage>e2302738120</StartPage><MedlinePgn>e2302738120</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2302738120</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.2302738120</ELocationID><Abstract><AbstractText>Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is characterized by various disabling symptoms including exercise intolerance and is diagnosed in the absence of a specific cause, making its clinical management challenging. A better understanding of the molecular mechanism underlying this apparent bioenergetic deficiency state may reveal insights for developing targeted treatment strategies. We report that overexpression of <i>Wiskott-Aldrich Syndrome Protein Family Member 3</i> (<i>WASF3</i>), here identified in a 38-y-old woman suffering from long-standing fatigue and exercise intolerance, can disrupt mitochondrial respiratory supercomplex formation and is associated with endoplasmic reticulum (ER) stress. Increased expression of <i>WASF3</i> in transgenic mice markedly decreased their treadmill running capacity with concomitantly impaired respiratory supercomplex assembly and reduced complex IV levels in skeletal muscle mitochondria. WASF3 induction by ER stress using endotoxin, well known to be associated with fatigue in humans, also decreased skeletal muscle complex IV levels in mice, while decreasing WASF3 levels by pharmacologic inhibition of ER stress improved mitochondrial function in the cells of the patient with chronic fatigue. Expanding on our findings, skeletal muscle biopsy samples obtained from a cohort of patients with ME/CFS showed increased WASF3 protein levels and aberrant ER stress activation. In addition to revealing a potential mechanism for the bioenergetic deficiency in ME/CFS, our study may also provide insights into other disorders associated with fatigue such as rheumatic diseases and long COVID.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Ping-Yuan</ForeName><Initials>PY</Initials><AffiliationInfo><Affiliation>Cardiovascular Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD 20892.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ma</LastName><ForeName>Jin</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiovascular Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD 20892.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Young-Chae</ForeName><Initials>YC</Initials><Identifier Source="ORCID">0000-0002-5130-4413</Identifier><AffiliationInfo><Affiliation>Cardiovascular Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD 20892.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Son</LastName><ForeName>Annie Y</ForeName><Initials>AY</Initials><AffiliationInfo><Affiliation>Cardiovascular Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD 20892.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Syed</LastName><ForeName>Abu Mohammad</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0003-0725-2609</Identifier><AffiliationInfo><Affiliation>Cardiovascular Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD 20892.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Chengyu</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-5136-9225</Identifier><AffiliationInfo><Affiliation>Transgenic Core, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD 20892.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mori</LastName><ForeName>Mateus P</ForeName><Initials>MP</Initials><Identifier Source="ORCID">0000-0003-1349-6378</Identifier><AffiliationInfo><Affiliation>Cardiovascular Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD 20892.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huffstutler</LastName><ForeName>Rebecca D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>Cardiovascular Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD 20892.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stolinski</LastName><ForeName>JoEllyn L</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>NIH MRI Research Facility, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD 20892.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Talagala</LastName><ForeName>S Lalith</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>NIH MRI Research Facility, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD 20892.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kang</LastName><ForeName>Ju-Gyeong</ForeName><Initials>JG</Initials><AffiliationInfo><Affiliation>Cardiovascular Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD 20892.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walitt</LastName><ForeName>Brian T</ForeName><Initials>BT</Initials><AffiliationInfo><Affiliation>Clinical Neurosciences Program, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD 20892.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nath</LastName><ForeName>Avindra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0927-5855</Identifier><AffiliationInfo><Affiliation>Clinical Neurosciences Program, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD 20892.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hwang</LastName><ForeName>Paul M</ForeName><Initials>PM</Initials><Identifier Source="ORCID">0000-0002-5976-7834</Identifier><AffiliationInfo><Affiliation>Cardiovascular Branch, National Heart, Lung, and Blood Institute, NIH, Bethesda, MD 20892.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Z01 HL005101</GrantID><Acronym>ImNIH</Acronym><Agency>Intramural NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C120153">WASF3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051300">Wiskott-Aldrich Syndrome Protein Family</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012119" MajorTopicYN="N">Respiration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051300" MajorTopicYN="N">Wiskott-Aldrich Syndrome Protein Family</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ER stress</Keyword><Keyword MajorTopicYN="N">WASF3</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword><Keyword MajorTopicYN="N">supercomplex</Keyword></KeywordList><CoiStatement>The authors declare no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>14</Day><Hour>15</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37579159</ArticleId><ArticleId IdType="pmc">PMC10450651</ArticleId><ArticleId IdType="doi">10.1073/pnas.2302738120</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bateman L., et al. , Myalgic encephalomyelitis/chronic fatigue syndrome: Essentials of diagnosis and management. Mayo. Clin. Proc. 96, 2861&#x2013;2878 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34454716</ArticleId></ArticleIdList></Reference><Reference><Citation>Institute of Medicine (U.S.), &#x201c;Committee on the diagnostic criteria for myalgic encephalomyelitis/chronic fatigue syndrome &amp; Institute of Medicine (U.S.). Board on the Health of Select Populations&#x201d; in Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness (The National Academies Press, Washington, D.C., 2015), p. XXI, 282 pp.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A. L., Lipkin W. I., Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome. Trends Mol. Med. 27, 895&#x2013;906 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8180841</ArticleId><ArticleId IdType="pubmed">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul B. D., Lemle M. D., Komaroff A. L., Snyder S. H., Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc. Natl. Acad. Sci. U.S.A. 118, e2024358118 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8403932</ArticleId><ArticleId IdType="pubmed">34400495</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeulen R. C., Vermeulen van Eck I. W., Decreased oxygen extraction during cardiopulmonary exercise test in patients with chronic fatigue syndrome. J. Transl. Med. 12, 20 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3903040</ArticleId><ArticleId IdType="pubmed">24456560</ArticleId></ArticleIdList></Reference><Reference><Citation>Lien K., et al. , Abnormal blood lactate accumulation during repeated exercise testing in myalgic encephalomyelitis/chronic fatigue syndrome. Physiol. Rep. 7, e14138 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6546966</ArticleId><ArticleId IdType="pubmed">31161646</ArticleId></ArticleIdList></Reference><Reference><Citation>Letts J. A., Sazanov L. A., Clarifying the supercomplex: The higher-order organization of the mitochondrial electron transport chain. Nat. Struct. Mol. Biol. 24, 800&#x2013;808 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28981073</ArticleId></ArticleIdList></Reference><Reference><Citation>Greggio C., et al. , Enhanced respiratory chain supercomplex formation in response to exercise in human skeletal muscle. Cell Metab. 25, 301&#x2013;311 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27916530</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez-Camacho I., Garcia-Nino W. R., Flores-Garcia M., Pedraza-Chaverri J., Zazueta C., Alteration of mitochondrial supercomplexes assembly in metabolic diseases. Biochim. Biophys. Acta Mol. Basis Dis. 1866, 165935 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32827648</ArticleId></ArticleIdList></Reference><Reference><Citation>Navid F., Colbert R. A., Causes and consequences of endoplasmic reticulum stress in rheumatic disease. Nat. Rev. Rheumatol. 13, 25&#x2013;40 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27904144</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoe T., Pathological aspects of COVID-19 as a conformational disease and the use of pharmacological chaperones as a potential therapeutic strategy. Front. Pharmacol. 11, 1095 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7366900</ArticleId><ArticleId IdType="pubmed">32754041</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosa-Fernandes L., et al. , SARS-CoV-2 activates ER stress and Unfolded protein response. bioRxiv [Preprint] (2021). 10.1101/2021.06.21.449284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.21.449284</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewsey S. C., et al. , Exercise intolerance and rapid skeletal muscle energetic decline in human age-associated frailty. JCI Insight 5, e141246 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7605538</ArticleId><ArticleId IdType="pubmed">32941181</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P. Y., et al. , Increased oxidative metabolism in the Li-Fraumeni syndrome. N. Engl. J. Med. 368, 1027&#x2013;1032 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4123210</ArticleId><ArticleId IdType="pubmed">23484829</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhuri A., Behan P. O., In vivo magnetic resonance spectroscopy in chronic fatigue syndrome. Prostaglandins Leukot. Essent. Fatty Acids 71, 181&#x2013;183 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15253888</ArticleId></ArticleIdList></Reference><Reference><Citation>Sossey-Alaoui K., Ranalli T. A., Li X., Bakin A. V., Cowell J. K., WAVE3 promotes cell motility and invasion through the regulation of MMP-1, MMP-3, and MMP-9 expression. Exp. Cell Res. 308, 135&#x2013;145 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15907837</ArticleId></ArticleIdList></Reference><Reference><Citation>Pihur V., Datta S., Datta S., Meta analysis of Chronic Fatigue Syndrome through integration of clinical, gene expression, SNP and proteomic data. Bioinformation 6, 120&#x2013;124 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3089886</ArticleId><ArticleId IdType="pubmed">21584188</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J., Wang G. C., Chen X. J., Xue Z. R., Expression of WASF3 in patients with non-small cell lung cancer: Correlation with clinicopathological features and prognosis. Oncol. Lett. 8, 1169&#x2013;1174 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4114608</ArticleId><ArticleId IdType="pubmed">25120680</ArticleId></ArticleIdList></Reference><Reference><Citation>Suetsugu S., Miki H., Takenawa T., Identification of two human WAVE/SCAR homologues as general actin regulatory molecules which associate with the Arp2/3 complex. Biochem. Biophys. Res. Commun. 260, 296&#x2013;302 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10381382</ArticleId></ArticleIdList></Reference><Reference><Citation>Sossey-Alaoui K., Su G., Malaj E., Roe B., Cowell J. K., WAVE3, an actin-polymerization gene, is truncated and inactivated as a result of a constitutional t (1;13)(q21;q12) chromosome translocation in a patient with ganglioneuroblastoma. Oncogene 21, 5967&#x2013;5974 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12185600</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghali A., et al. , Elevated blood lactate in resting conditions correlate with post-exertional malaise severity in patients with Myalgic encephalomyelitis/Chronic fatigue syndrome. Sci. Rep. 9, 18817 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6906377</ArticleId><ArticleId IdType="pubmed">31827223</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisloff U., et al. , Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. Science 307, 418&#x2013;420 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15662013</ArticleId></ArticleIdList></Reference><Reference><Citation>Teng Y., et al. , Mitochondrial ATAD3A combines with GRP78 to regulate the WASF3 metastasis-promoting protein. Oncogene 35, 333&#x2013;343 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4828935</ArticleId><ArticleId IdType="pubmed">25823022</ArticleId></ArticleIdList></Reference><Reference><Citation>Loveless R., Teng Y., Targeting WASF3 signaling in metastatic cancer. Int. J. Mol. Sci. 22, 836 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7830529</ArticleId><ArticleId IdType="pubmed">33467681</ArticleId></ArticleIdList></Reference><Reference><Citation>Jha P., Wang X., Auwerx J., Analysis of mitochondrial respiratory chain supercomplexes using blue native polyacrylamide gel electrophoresis (BN-PAGE). Curr. Protoc. Mouse Biol. 6, 1&#x2013;14 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4823378</ArticleId><ArticleId IdType="pubmed">26928661</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Vizarra E., Zeviani M., Mitochondrial complex III Rieske Fe-S protein processing and assembly. Cell Cycle 17, 681&#x2013;687 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5969560</ArticleId><ArticleId IdType="pubmed">29243944</ArticleId></ArticleIdList></Reference><Reference><Citation>Protasoni M., Zeviani M., Mitochondrial structure and bioenergetics in normal and disease conditions. Int. J. Mol. Sci. 22 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7827222</ArticleId><ArticleId IdType="pubmed">33435522</ArticleId></ArticleIdList></Reference><Reference><Citation>Behan W. M., More I. A., Behan P. O., Mitochondrial abnormalities in the postviral fatigue syndrome. Acta Neuropathol. 83, 61&#x2013;65 (1991).</Citation><ArticleIdList><ArticleId IdType="pubmed">1792865</ArticleId></ArticleIdList></Reference><Reference><Citation>Myhill S., Booth N. E., McLaren-Howard J., Chronic fatigue syndrome and mitochondrial dysfunction. Int. J. Clin. Exp. Med. 2, 1&#x2013;16 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2680051</ArticleId><ArticleId IdType="pubmed">19436827</ArticleId></ArticleIdList></Reference><Reference><Citation>Stussman B., et al. , Characterization of post-exertional malaise in patients with myalgic encephalomyelitis/Chronic Fatigue Syndrome. Front. Neurol. 11, 1025 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7530890</ArticleId><ArticleId IdType="pubmed">33071931</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattarai K. R., Chaudhary M., Kim H. R., Chae H. J., Endoplasmic reticulum (ER) stress response failure in diseases. Trends Cell Biol. 30, 672&#x2013;675 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32561138</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayavarapu S., Coley W., Nagaraju K., Endoplasmic reticulum stress in skeletal muscle homeostasis and disease. Curr. Rheumatol. Rep. 14, 238&#x2013;243 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3587844</ArticleId><ArticleId IdType="pubmed">22410828</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z. T., et al. , Activation of the NLRP3 inflammasome in lipopolysaccharide-induced mouse fatigue and its relevance to chronic fatigue syndrome. J. Neuroinflammation 13, 71 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4822300</ArticleId><ArticleId IdType="pubmed">27048470</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster C. G., Landowski L. M., Sutherland B. A., Howells D. W., Differences in fatigue-like behavior in the lipopolysaccharide and poly I: C inflammatory animal models. Physiol. Behav. 232, 113347 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33529685</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasselin J., et al. , Fatigue and sleepiness responses to experimental inflammation and exploratory analysis of the effect of baseline inflammation in healthy humans. Brain Behav. Immun. 83, 309&#x2013;314 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31682972</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Q., et al. , Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation. Hepatology 36, 592&#x2013;601 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12198651</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyce M., et al. , A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science 307, 935&#x2013;939 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15705855</ArticleId></ArticleIdList></Reference><Reference><Citation>Peralta S., et al. , ATAD3 controls mitochondrial cristae structure in mouse muscle, influencing mtDNA replication and cholesterol levels. J. Cell Sci. 131, jcs217075 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6051345</ArticleId><ArticleId IdType="pubmed">29898916</ArticleId></ArticleIdList></Reference><Reference><Citation>Pagliarini D. J., et al. , A mitochondrial protein compendium elucidates complex I disease biology. Cell 134, 112&#x2013;123 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2778844</ArticleId><ArticleId IdType="pubmed">18614015</ArticleId></ArticleIdList></Reference><Reference><Citation>Pekkurnaz G., Wang X., Mitochondrial heterogeneity and homeostasis through the lens of a neuron. Nat. Metab. 4, 802&#x2013;812 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11151822</ArticleId><ArticleId IdType="pubmed">35817853</ArticleId></ArticleIdList></Reference><Reference><Citation>Mick D. U., et al. , Shy1 couples Cox1 translational regulation to cytochrome c oxidase assembly. EMBO J. 26, 4347&#x2013;4358 (2007).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2034671</ArticleId><ArticleId IdType="pubmed">17882259</ArticleId></ArticleIdList></Reference><Reference><Citation>Timon-Gomez A., et al. , Mitochondrial cytochrome c oxidase biogenesis: Recent developments. Semin Cell Dev. Biol. 76, 163&#x2013;178 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5842095</ArticleId><ArticleId IdType="pubmed">28870773</ArticleId></ArticleIdList></Reference><Reference><Citation>Bourens M., Barrientos A., A CMC1-knockout reveals translation-independent control of human mitochondrial complex IV biogenesis. EMBO Rep. 18, 477&#x2013;494 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5331208</ArticleId><ArticleId IdType="pubmed">28082314</ArticleId></ArticleIdList></Reference><Reference><Citation>Rojas M., Vasconcelos G., Dever T. E., An eIF2alpha-binding motif in protein phosphatase 1 subunit GADD34 and its viral orthologs is required to promote dephosphorylation of eIF2alpha. Proc. Natl. Acad. Sci. U.S.A. 112, E3466&#x2013;E3475 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4500263</ArticleId><ArticleId IdType="pubmed">26100893</ArticleId></ArticleIdList></Reference><Reference><Citation>Lane R. J., Soteriou B. A., Zhang H., Archard L. C., Enterovirus related metabolic myopathy: A postviral fatigue syndrome. J. Neurol. Neurosurg. Psychiatry 74, 1382&#x2013;1386 (2003).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1757378</ArticleId><ArticleId IdType="pubmed">14570830</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein S. R., et al. , SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature 612, 758&#x2013;763 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Argov Z., Lofberg M., Arnold D. L., Insights into muscle diseases gained by phosphorus magnetic resonance spectroscopy. Muscle Nerve 23, 1316&#x2013;1334 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10951434</ArticleId></ArticleIdList></Reference><Reference><Citation>Patino W. D., et al. , Circulating transcriptome reveals markers of atherosclerosis. Proc. Natl. Acad. Sci. U.S.A. 102, 3423&#x2013;3428 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC552911</ArticleId><ArticleId IdType="pubmed">15728378</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J. Y., et al. , p53 improves aerobic exercise capacity and augments skeletal muscle mitochondrial DNA content. Circ. Res. 105, 705&#x2013;712 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2761626</ArticleId><ArticleId IdType="pubmed">19696408</ArticleId></ArticleIdList></Reference><Reference><Citation>Frezza C., Cipolat S., Scorrano L., Organelle isolation: Functional mitochondria from mouse liver, muscle and cultured fibroblasts. Nat. Protoc. 2, 287&#x2013;295 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17406588</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimauro I., Pearson T., Caporossi D., Jackson M. J., A simple protocol for the subcellular fractionation of skeletal muscle cells and tissue. BMC Res. Notes 5, 513 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3508861</ArticleId><ArticleId IdType="pubmed">22994964</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Sage V., Cinti A., Mouland A. J., Proximity-dependent biotinylation for identification of interacting proteins. Curr. Protoc. Cell Biol. 73, 17 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27906451</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P. -y., et al. ., WASF3 disrupts mitochondrial respiration and may mediate exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome. Primary data folders. FigShare. 10.25444/nhlbi.23681013. Deposited 13 July 2023.</Citation><ArticleIdList><ArticleId IdType="doi">10.25444/nhlbi.23681013</ArticleId><ArticleId IdType="pmc">PMC10450651</ArticleId><ArticleId IdType="pubmed">37579159</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>